|
1
|
Sundar S, Neal RD and Kehoe S: Diagnosis
of ovarian cancer. BMJ. 351:h44432015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burke AJ, Sullivan FJ, Giles FJ and Glynn
SA: The yin and yang of nitric oxide in cancer progression.
Carcinogenesis. 34:503–512. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lala PK and Chakraborty C: Role of nitric
oxide in carcinogenesis and tumour progression. Lancet Oncol.
3:149–156. 2001. View Article : Google Scholar
|
|
4
|
Fukumura D, Kashiwagi S and Jain RK: The
role of nitric oxide in tumour progression. Nat Rev Cancer.
6:521–534. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rao CV: Nitric oxide signaling in colon
cancer chemoprevention. Mutat Res. 555:107–119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ridnour LA, Thomas DD, Switzer C,
Flores-Santana W, Isenberg JS, Ambs S, Roberts DD and Wink DA:
Molecular mechanisms for discrete nitric oxide levels in cancer.
Nitric Oxide. 19:73–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fetz V, Bier C, Habtemichael N, Schuon R,
Schweitzer A, Kunkel M, Engels K, Kovacs AF, Schneider S, Mann W,
et al: Inducible NO synthase confers chemoresistance in head and
neck cancer by modulating survivin. Int J Cancer. 124:2033–2041.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matthews NE, Adams MA, Maxwell LR, Gofton
TE and Graham CH: Nitric oxide-mediated regulation of
chemosensitivity in cancer cells. J Natl Cancer Inst. 93:1879–1885.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leung EL, Fraser M, Fiscus RR and Tsang
BK: Cisplatin alters nitric oxide synthase levels in human ovarian
cancer cells: Involvement in p53 regulation and cisplatin
resistance. Br J Cancer. 98:1803–1809. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Robey RW, To KK, Polgar O, Dohse M, Fetsch
P, Dean M and Bates SE: ABCG2: A perspective. Adv Drug Deliv Rev.
61:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakanishi T and Ross DD: Breast cancer
resistance protein (BCRP/ABCG2): Its role in multidrug resistance
and regulation of its gene expression. Chin J Cancer. 31:73–99.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brechbuhl HM, Gould N, Kachadourian R,
Riekhof WR, Voelker DR and Day BJ: Glutathione transport is a
unique function of the ATP-binding cassette protein ABCG2. J Biol
Chem. 285:16582–16587. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Valko M, Leibfritz D, Moncol J, Cronin MT,
Mazur M and Telser J: Free radicals and antioxidants in normal
physiological functions and human disease. Int J Biochem Cell Biol.
39:44–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim BR, Seo SH, Park MS, Lee SH, Kwon Y
and Rho SB: sMEK1 inhibits endothelial cell proliferation by
attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.
Oncotarget. 6:31830–31843. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gangula P, Ravella K, Chukkapalli S,
Rivera M, Srinivasan S, Hale A, Channon K, Southerland J and
Kesavalu L: Polybacterial periodontal pathogens alter vascular and
gut BH4/nNOS/NRF2-Phase II enzyme expression. PLoS One.
10:e01298852015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Castaldo SA, Freitas JR, Conchinha NV and
Madureira PA: The tumorigenic roles of the cellular REDOX
regulatory systems. Oxid Med Cell Longev. 2016:84130322016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Malpica A, Deavers MT, Lu K, Bodurka DC,
Atkinson EN, Gershenson DM and Silva EG: Grading ovarian serous
carcinoma using a two-tier system. Am J Surg Pathol. 28:496–504.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baig MS, Zaichick SV, Mao M, de Abreu AL,
Bakhshi FR, Hart PC, Saqib U, Deng J, Chatterjee S, Block ML, et
al: NOS1-derived nitric oxide promotes NF-kB transcriptional
activity through inhibition of suppressor of cytokine signaling-1.
J Exp Med. 212:1725–1738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Penzvalto Z, Lanczky A, Lénárt J,
Meggyesházi N, Krenács T, Szoboszlai N, Denkert C, Pete I and
Győrffy B: MEK1 is associated with carboplatin resistance and is a
prognostic biomarker in epithelial ovarian cancer. BMC Cancer.
14:8372014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thomas DD, Ridnour LA, Isenberg JS,
Flores-Santana W, Switzer CH, Donzelli S, Hussain P, Vecoli C,
Paolocci N, Ambs S, et al: The chemical biology of nitric oxide:
Implications in cellular signaling. Free Radic Biol Med. 45:18–31.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu W, Liu LZ, Loizidou M, Ahmed M and
Charles IG: The role of nitric oxide in cancer. Cell Res.
12:311–320. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vannini F, Kashfi K and Nath N: The dual
role of iNOS in cancer. Redox Biol. 6:334–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nathan C and Xie QW: Nitric oxide
synthases: Roles, tolls, and controls. Cell. 78:915–918. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X, Wu X, Wang C, Zhang W, Ouyang Y,
Yu Y and He Z: Transcriptional suppression of breast cancer
resistance protein (BCRP) by wild-type p53 through the NF-kappaB
pathway in MCF-7 cells. FEBS Lett. 584:3392–3397. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singh A, Wu H, Zhang P, Happel C, Ma J and
Biswal S: Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer
cells that confers side population and chemoresistance phenotype.
Mol Cancer Ther. 9:2365–2376. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Martin CM, Ferdous A, Gallardo T,
Humphries C, Sadek H, Caprioli A, Garcia JA, Szweda LI, Garry MG
and Garry DJ: Hypoxia-inducible factor-2alpha transactivates Abcg2
and promotes cytoprotection in cardiac side population cells. Circ
Res. 102:1075–1081. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: New opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Esteban FJ, Horcajadas A, El-Rubaidi O,
Luque-Barona R, Ibáñez G, Garcia-Carriazo A, Segovia M and del
Moral-Leal ML: Nitric oxide in malignant astrocytes. Rev Neurol.
40:437–440. 2005.(In Spanish). PubMed/NCBI
|
|
31
|
Yang DI, Yin JH, Mishra S, Mishra R and
Hsu CY: NO-mediated chemoresistance in C6 glioma cells. Ann N Y
Acad Sci. 962:8–17. 2002. View Article : Google Scholar : PubMed/NCBI
|
